Navigation Links
Atonomics and OMRON Healthcare Enter Agreement for Equity Investment
Date:12/9/2013

COPENHAGEN, Denmark, December 9, 2013 /PRNewswire/ --

Investment will Aid Atonomics in Development of an Advanced Platform for Testing of Lifestyle Diseases

     (Logo: http://photos.prnewswire.com/prnh/20121126/578019)

Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the Atolyzer®Consumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.

The Atolyzer®Consumer device is the initial product line under the Atolyzer®Platform, a fully integrated immuno-, metabolic-, and molecular diagnostic platform, designed to deliver central laboratory performance in a near-patient environment. The platform consists of three devices currently under development: Atolyzer®Consumer, Atolyzer®PoC and Atolyzer®Gene.

Atonomics is targeting to create a paradigm shift in how lifestyle diseases are managed today. "We want to change the way people are going to controls at the GP office for a yearly check-up of their type-2 diabetes or heart problem to be able in the future additionally to monitor and manage their disease status actively towards less disease complications and simply a better quality of life," says Thomas Warthoe, Atonomics' CEO.

"The Atolyzer®Consumer device combines small size, ease of use, portability and low cost in a system that is based on well-established chemistries, reagents, and technologies. We look forward to assisting Atonomics in moving this technology towards commercialization," says Kiichiro Miyata, President and CEO of Omron Healthcare.

This collaboration re-emphasizes the development pathway that Atonomics has embarked upon, and duly stresses the need to offer cost effective convenience based point-of care diagnostics in the molecular space. We welcome the addition to our existing impressive syndicate, which includes Beckman Coulter, of Omron, a world-class consumer-oriented company, which has clearly recognized our strategic vision. We look forward to working together in bringing this offering to the consumer", says Ashok Dhanrajgir, Board Director at Atonomics and Senior Partner at Inventages.

About Atonomics

Atonomics is an emerging technology company based in Copenhagen, Denmark that designs and manufactures the innovative Atolyzer®Platform for near-patient testing and monitoring in pharmacies, clinics, physician offices and hospitals. Atonomics is pursuing a strategy to partner with leading players in the industry to bring a new dimension of quality to the decentral Dx testing segments. The Atolyzer® is designed for simplicity and ease of use while preserving performance and safety. The stand-alone device is operated with a single touch by any person and can be positioned in any location where larger systems cannot operate, representing true near-patient testing.

About Omron Healthcare

Committed to improving people's lives, Omron Healthcare provides clinically proven, innovative medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, respiratory devices, electronic fever thermometers, blood glucose monitors and activity monitors as well as body composition monitors and professional medical devices. For many decades Omron's devices have helped people to prevent, treat and manage lifestyle diseases both at home and in clinical practice in more than 100 countries around the world. Omron Healthcare Group is headquartered in Kyoto, Japan. Omron Healthcare Europe B.V. is the healthcare division for Europe, Russia, Middle East and Africa and provides services to customers in more than 60 countries through a powerful distribution network.

Contacts:

Atonomics
Thomas Warthoe, CEO
Phone: +45-70271330
E-mail: tw@atonomics.com
Web: http://www.atonomics.com


'/>"/>
SOURCE Atonomics A/S
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Atonomics Achieves Significant Milestone Related to Performance Data for Troponin I Assay Triggering Scheduled Payments From Beckman Coulter
2. Omron Healthcare Announces New Over-The-Counter Electrotherapy Device
3. Omron Healthcare Announces New Pedometers
4. Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference
5. HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast
6. Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
7. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
8. Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference
9. Rigel to Present at Oppenheimer Healthcare Conference
10. Omeros to Present at Oppenheimer 24th Annual Healthcare Conference
11. Neurocrine Biosciences To Present At Oppenheimers 24th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... Transparency Market Research states that the ...  held a huge share of 43% in 2015. Apple Inc., ... the overall market, grabbing the undivided attention of buyers with ... and strong product portfolio is expected to keep these companies ... ...
(Date:1/16/2017)... TORONTO , Jan. 16, 2017  Today, Analytics ... cost-effective medical devices, announced its expansion into JLABS @ ... Johnson Innovation,s life science incubators. As a resident in ... of cardiovascular medical device development and commercialization expertise. ... a life science innovation center that provides a flexible ...
(Date:1/15/2017)... January 16, 2017 Der Vorstand ... für die Regeneration des menschlichen Gewebes, gibt die Ernennung ... sofortiger Wirkung bekannt. ... Bill Allan ist ... bekleidete eine Reihe von Geschäftsführer- und anderen Führungspositionen bei ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... 2017 , ... To provide comfort and fuel during the ... category, announces a hearty and wholesome Winter Menu. Starting today, guests can enjoy ... Cranberry Crunch & Honey Parfait, Slow Cooked Smoky Chicken & Sausage Soup, and ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... ... products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF ... in Las Vegas, Booth #2809. The SHOT Show is the shooting, hunting and ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... announced the addition of Victor Giamos, MD to their medical staff, according to ... Partner at North Shore Eye Care, a division of SightMD. Dr. Giamos will ...
(Date:1/16/2017)... ... January 16, 2017 , ... St. Louisans are well-aware of the following facts at present:, ... year’s influenza shot seems to be having no effect on keeping this particularly bad strain ... the people around are coughing, sneezing, or sniffling , These facts are ...
(Date:1/16/2017)... ... 2017 , ... One thing common to all types of cancer is that ... well. The money spent screening for and treating cancer in the United States is ... cancer more than in any other country that has an advanced healthcare system, sometimes ...
Breaking Medicine News(10 mins):